/ /

  • linkedin
  • Increase Font
  • Sharebar

    Selecting the right DME patients for long-term steroidal implants

     

    Lighten the burden

    The bioerodable implant offers my patients an alternative treatment when anti-VEGF therapy is not sufficient. With the long-acting corticosteroid implant, patients once consigned to severe visual impairment now have another good option. This long-term treatment lightens the burden of frequent office visits and injections while still producing outcomes comparable to existing therapies. My patients gain independence, and I am rewarded with grateful patients and knowing that I have helped improve their lives.

     

    Joshua Mali, MD, is a vitreoretinal surgeon at The Eye Associates, a private multispecialty ophthalmology practice in Sarasota, Florida. He can be reached at 941-792-2020. He is currently a consultant and shareholder at Alimera Sciences and a consultant at Allergan, where he also conducts research and receives clinical study funding.     

    Joshua Mali, MD
    Joshua Mali, MD, is a vitreoretinal surgeon at The Eye Associates, a private multispecialty ophthalmology practice in Sarasota, Florida.

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results